These tumours have alterations in chromosomal numbers and are associated with mutations in MET, CDKN2A, SETD2, BAP1, PBRM1, NFE2L2, and mTOR genes and have a better prognosis when compared with clear cell RCC in the organ-confined stage (7). Here, MET is linked to neoplasm.